{"id":"https://openalex.org/W2440520232","doi":null,"title":"Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma.","display_name":"Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma.","publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W2440520232","mag":"2440520232","pmid":"https://pubmed.ncbi.nlm.nih.gov/12530014"},"language":"en","primary_location":{"id":"pmid:12530014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12530014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109948831","display_name":"Anil Potti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil Potti","raw_affiliation_strings":["Department of Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, ND 58102, USA. apotti@medicine.nodak.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, ND 58102, USA. apotti@medicine.nodak.edu","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024497224","display_name":"Apar Kishor Ganti","orcid":"https://orcid.org/0000-0003-3724-2671","observed_orcids":["https://orcid.org/0000-0003-3724-2671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Apar Kishor Ganti","raw_affiliation_strings":["Oncology/Hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology/Hematology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111883393","display_name":"Steve A. Kargas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Kargas","raw_affiliation_strings":["IMPATH, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPATH, Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Michael Koch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Koch","raw_affiliation_strings":["MeritCare Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MeritCare Hospital","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9873,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.87387813,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"22","issue":"5","first_page":"2899","last_page":"901"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":1.0},{"id":"https://openalex.org/keywords/c-kit","display_name":"CD117","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9929999709129333},{"id":"https://openalex.org/keywords/vegf-overexpression","display_name":"VEGF overexpression","score":0.9760000109672546},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6669999957084656},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8230000138282776},{"id":"https://openalex.org/keywords/vegf-inhibitors","display_name":"VEGF inhibitors","score":0.9160000085830688},{"id":"https://openalex.org/keywords/signal-transduction-inhibition","display_name":"signal transduction inhibition","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cd5","display_name":"CD5","score":0.6859999895095825},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C2776839831","wikidata":"https://www.wikidata.org/wiki/Q909409","display_name":"CD117","level":4,"score":0.7436206340789795},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6762804985046387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6463215351104736},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5474026203155518},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5188190340995789},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.5027782917022705},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.46581530570983887},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.460160493850708},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4588736593723297},{"id":"https://openalex.org/C199835354","wikidata":"https://www.wikidata.org/wiki/Q15311861","display_name":"Cyclin D1","level":4,"score":0.424612820148468},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.41279760003089905},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3582903742790222},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3255819082260132},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27779775857925415},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2610587477684021},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.19991183280944824},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.08897173404693604},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.08506733179092407},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008222","descriptor_name":"Lymphokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016228","descriptor_name":"Endothelial Growth Factors","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D042442","descriptor_name":"Vascular Endothelial Growth Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12530014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12530014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2440520232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12530014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393072474","https://openalex.org/W3214310608","https://openalex.org/W4377013001","https://openalex.org/W2909112374","https://openalex.org/W2066583865","https://openalex.org/W4289756658","https://openalex.org/W7170142617","https://openalex.org/W2595353436","https://openalex.org/W2112203120","https://openalex.org/W2073098553"],"abstract_inverted_index":{"BACKGROUND:":[0],"Mantle":[1],"cell":[2],"lymphoma":[3],"(MCL)":[4],"is":[5,11],"a":[6,60,121,181,235,239],"low-grade":[7],"lymphoproliferative":[8],"malignancy":[9],"that":[10],"extremely":[12],"refractory":[13],"to":[14,48,252],"chemotherapy.":[15],"Commonly":[16],"used":[17],"treatments":[18],"have":[19],"yielded":[20],"unfavorable":[21],"response":[22],"rates":[23],"(30%":[24],"complete":[25],"remission).":[26],"We":[27],"evaluated":[28,208],"the":[29,77,102,155,162,209,254],"incidence":[30],"of":[31,62,124,148,184,198,211,223,242,256],"c-kit":[32,212],"(CD117)":[33],"and":[34,73,108,213],"vascular":[35],"endothelial":[36],"growth":[37],"factor":[38],"(VEGF)":[39],"overexpression":[40,89,215],"in":[41,45,84,145,194,202,216,238,258],"patients":[42,113,151,157,172,201,243],"with":[43,59,69,114,120,152,244],"MCL":[44,63,115],"an":[46],"effort":[47],"identify":[49],"possible":[50],"targets":[51],"for":[52],"therapeutic":[53,224],"intervention.":[54],"MATERIALS":[55],"AND":[56],"METHODS:":[57],"Patients":[58],"diagnosis":[61],"based":[64],"on":[65,76,94],"CD5":[66],"positivity":[67,72],"associated":[68],"cyclin":[70],"D1":[71],"CD23":[74],"negativity":[75],"lymph":[78],"node/bone":[79],"marrow":[80],"specimen":[81],"were":[82],"included":[83],"our":[85,203],"retrospective":[86],"study.":[87,204],"CD117":[88,190,219],"was":[90,99,135,143,165,192],"performed":[91],"using":[92,231],"immunohistochemistry":[93],"archival":[95],"specimens.":[96],"VEGF":[97,141,174,214,257],"expression":[98,142,175,191],"detected":[100],"by":[101],"avidin-biotin-complex":[103],"method.":[104],"RESULTS:":[105],"Between":[106],"1997":[107],"2001,":[109],"we":[110],"identified":[111,144,193],"17":[112,149,199],"(9":[116],"males,":[117],"8":[118],"females)":[119],"mean":[122,132,163,182],"age":[123],"57":[125],"years":[126],"(age":[127],"range:":[128],"42-66":[129],"years).":[130],"The":[131],"overall":[133],"survival":[134,164,183],"34":[136],"months":[137,167,186],"(range:":[138,168,187],"11-60":[139],"months).":[140,189],"7":[146],"out":[147,197],"(41.18%)":[150],"MCL.":[153,217,245,259],"Among":[154],"VEGF-positive":[156],"(n":[158,176],"=":[159,177],"7,":[160],"41.1%),":[161],"24":[166],"11-42":[169],"months),":[170],"while":[171],"without":[173],"10,":[178],"58.9%)":[179],"had":[180],"44":[185],"21-60":[188],"only":[195],"2":[196],"(1.17%)":[200],"CONCLUSION:":[205],"Our":[206],"study":[207],"role":[210,255],"Although":[218],"may":[220,233],"not":[221],"be":[222,234],"significance,":[225],"target-directed":[226],"signal":[227],"transduction":[228],"inhibition":[229],"therapy":[230],"VEGF-inhibitors":[232],"distinct":[236],"possibility":[237],"select":[240],"group":[241],"Future":[246],"larger":[247],"studies":[248],"are":[249],"urgently":[250],"needed":[251],"elaborate":[253]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}